Limitless Biotech score history

Score over time

Every entry newest first

1. November 5, 2026Raised from6.90→to6.97(+0.07)

   Pricing re-checked on 5 November 2026 after the market medians were recalculated with Peptyes added pricing 4.6 to 5.1.

2. November 5, 2026Raised from6.84→to6.90(+0.06)

   Pricing re-checked on 5 November 2026 after the market medians were recalculated pricing 4.2 to 4.6.

3. November 3, 2026Lowered from6.85→to6.84(-0.01)

   Market medians updated on 3 November 2026 after the NextGen Peps re-check added priced listings: pricing 4.3 to 4.2.

4. October 22, 2026Raised from6.41→to6.85(+0.44)

   Lab score recalculated on 22 October 2026 under the published core-product rule (A1b): a missing certificate on one of the 15 most widely carried products still counts fully, while on any other product it now counts at half weight, so a broad catalogue is not penalised as much for its breadth. Lab 6.7 to 7.5.

5. October 22, 2026Raised from6.31→to6.41(+0.10)

   Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: shipping and refunds 6.5 to 7.0.

6. October 22, 2026Lowered from7.34→to6.31(-1.03)

   Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 9.0 to 6.5, pricing 7.2 to 4.3, operating history 6.5 to 9.1, transparency 9.0 to 4.5.

7. October 22, 2026Raised from7.29→to7.34(+0.05)

   Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for site statements about testing that the certificates do not bear out. Lab 6.6 to 6.7.

8. October 21, 2026Lowered from7.46→to7.29(-0.17)

   Tenure 10 to 6.5. The company states it has operated since 2020, about six years, which falls below the top band reserved for businesses over ten years. Lab and the other subscores are unchanged.

9. October 20, 2026Lowered from8.55→to7.46(-1.09)

   Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 15 of the 19 products we list that the vendor offers for sale. Lab 8.6 to 6.6.

10. July 23, 2026Re-checked, no change

    Re-audited from live COAs, verified firsthand. Confirmed a strong dual-lab program -- TrustPointe (including rare USP<71> sterility testing) plus Janoshik, all independently verifiable at 99%+ purity. Rating held; fill variation observed but not scored against the vendor per policy.